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Abstract
Liposarcomas are exceedingly rare entities that evoke malignant transformation of connective
tissue and fat cells. These tumours occur throughout the soft tissues of the body, afflicting a
myriad of regions. In the adult population, liposarcomas represent the most prevalent subtype
of sarcomas, and often arise de novo. Retroperitoneal liposarcomas (RLS) are a ubiquitous
subset of sarcomas that, due to their deep location in the hollow abdomen, can grow to
astronomical proportions before manifesting any noticeable symptoms; a prompt diagnosis of
RLS is therefore often rendered dilatory. We hereby delineate the case of a 43-year-old woman
who presented with vague left hemiabdominal distention and discomfort. A subsequent
computed tomography scan divulged a giant retroperitoneal growth impaling on and thus
displacing the pancreas. A compartmental, en bloc resection was performed, with subsequent
histopathology of the excised specimen revealing a well-differentiated liposarcoma. The
surgical intervention was curative and led to an uneventful recovery. This paper highlights the
pertinence of surgical management as an appropriate treatment modality for a complete
resection of RLS. 
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Introduction
Liposarcomas are malignant tumours of mesenchymal cells that can infiltrate a plethora of soft
tissues in the body. Retroperitoneal sarcomas encompass tumours that are mesenchymal in
origin and arise from the retroperitoneum. Of all retroperitoneal sarcomas, retroperitoneal
liposarcomas (RLS) are established to be the most prevalent [1]. Due to their location in the
hollow abdomen, retroperitoneal sarcomas, including RLS, can often evade early detection,
manifesting signs and symptoms characteristic of an abnormal growth only with advanced
disease. Merely 10%-20% of sarcomas are believed to be retroperitoneal sarcomas [2].
Pertinently, retroperitoneal sarcomas have a high resectability rate, soaring to as high as 95%
according to a study [3]. While the resection of RLS can yield fecund post-operative outcomes
in a majority of the cases, an advanced tumour, one encasing adjacent organs, tissues, and
structures, can present a surgical conundrum. We hereby elucidate the case of a 43-year-old
female presenting with a giant RLS encasing the left kidney, splenic flexure, descending colon,
and the left kidney. Due to extensive encasement of adjacent structures, an en bloc resection
was deemed apt; its adept execution, however, presented an exacting surgical challenge. 
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Case Presentation
We delineate the case of a 43-year-old female who presented to our department with a two-
year history of persistent discomfort in her left abdomen and associated vague abdominal
heaviness. The patient had no comorbid conditions, and her past medical and surgical histories
were unremarkable. Since the inception of her symptoms, she had experienced concomitant
constipation for which she had seen a physician in her remote village. Due to an acute
presentation, and no associated red-flag signs, the physician attributed the constipation to the
patient’s history of consuming a diet bereft of high-fibre foods. In the six months that
followed, the patient began to appreciate a painful, poorly demarcated abdominal lump, for
which she ultimately underwent an ultrasound one month prior to presenting to us. The
ultrasound divulged an abnormal growth in the left hemiabdomen; further imaging, however,
was deemed necessary in order to yield a definitive diagnosis. At presentation, the patient had a
huge, palpable abdominal mass that was firm and non-tender. The mass was noted to be in the
left hemiabdomen, and appeared to extend from her left hypochondrium to the left iliac fossa,
ostensibly traversing the midline. Thereafter, the patient was advised to under undergo a
computed tomography (CT) scan of her chest, abdomen, and pelvis. The contrast-enhanced CT
scan revealed a giant retroperitoneal mass, measuring 50 x 40 x 30 cm. The CT scan showed
that the giant retroperitoneal growth was boring behind the pancreas, displacing it supero-
anteriorly. Furthermore, the tumour was also noted to be impaled on the splenic hilum, thereby
displacing the spleen laterally (Figure 1).
FIGURE 1: Contrast-enhanced CT scan of the abdomen and
pelvis showing a retroperitoneal growth (yellow arrow)
displacing the spleen (red arrow) laterally and the stomach
medially.
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The CT scan further revealed that the retroperitoneal tumour was in fact completely encasing
the left kidney, displacing it medially and across the midline. Moreover, based on the CT
findings, it was aptly construed that the massive retroperitoneal growth was indeed crossing
the midline itself, entirely encasing the splenic flexure and the descending colon (Figure 2). 
FIGURE 2: An intravenous contrast CT image showing
complete encasement of her left kidney, ureter, and the
descending colon by the tumour (arrows).
A subsequent CT-guided core biopsy revealed a well-differentiated liposarcoma. Due to the
extensive encasement of adjacent structures by the tumour, the case was discussed at a
multidisciplinary team meeting (MDT), which involved the pathologist, an oncological surgeon,
general surgeon, and the radiologist. A surgery was promptly planned, and an en
bloc compartmental resection approach for the excision of the tumour and the encased
structures was performed (Figure 3). 
2020 Almas et al. Cureus 12(6): e8730. DOI 10.7759/cureus.8730 3 of 7
FIGURE 3: The inferior vena cava (IVC), the aorta and
bifurcation into iliacs is visible; pancreatic tail and spleen,
visibly clear of tumour margins, are seen after a seamless
resection of the mass.
A successful en bloc resection of the mass, with the encased kidney and involved colon, yielded
the specimen (Figure 4). Additionally, Hartmann’s procedure was performed due to extensive
colonic involvement.
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FIGURE 4: The resected en bloc specimen measuring roughly
40 x 30 cm.
The excised sample was subsequently sent for histopathology, which revealed fibroadipose and
fibromuscular tissue infiltrated by an adipocytic lesion composed of variably sized mature
adipocytes and bands of fibrotic stroma containing atypical spindle to stellate stromal cells.
Enlarged, hyperchromatic nuclei were appreciated with prominent nucleoli and scant mitoses.
The spindle cells, in particular, demonstrated mild atypia on a background of present
lipoblasts. Sections examined revealed that both the attached bowel and kidney wall were
tumour-free.
Post-operatively, the patient's recovery was uneventful and the patient was discharged on the
fourth day post-operatively. To date, at one-year follow-up, the patient continues to thrive and
do well, with no recurrence(s). 
Discussion
Liposarcomas are specific subtypes of sarcomas that involve the soft tissues [4]. Although they
can be found in a myriad of regions, liposarcomas are found in the retroperitoneal region
around half the time. The tumours can be differentiated into three distinct histologic and
genetic subtypes, such as dedifferentiated liposarcoma (DDLS), well-differentiated,
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myxoid/round cell liposarcoma, and pleomorphic liposarcoma. Regardless of the type of
liposarcoma, surgical excision remains the most efficacious treatment modality [4]. These
tumours present both diagnostic and therapeutic challenges as they are difficult to palpate on
physical examination, and an inability to completely excise the tumour predisposes to the
possibility of a recurrence. The tumour is believed to mainly afflict male patients between the
ages of 40 and 60 years [5]. Although a multitude of sarcomas can be found in the
retroperitoneal region, RLS remains the most common subtype [6]. The expansive anatomical
spaces afforded by the retroperitoneum, along with the tendency of RLS to locally invade, mean
that the tumour frequently evades detection and presents with symptoms only with advanced
sizes [6]. The subtype of the tumours further governs the prognosis, with DDLS presenting with
a recurrence rate of over 80% [4,6]. Well-differentiated tumours have a 100% five-year survival
rate, followed by an 88% survival rate afforded by myxoid liposarcomas [7].
RLS generally present with a progressive increase in abdominal girth that does not subside
[4,5]. Patients may also present with diffuse abdominal pain and fever lasting one to two weeks
[6]. Upon suspicion, patients subsequently undergo CT scans of the abdomen and pelvis to
determine the extent of tumour invasion. MDT consultations play a pivotal role in the
management of liposarcomas [8]. Surgical excision remains the most effective treatment
modality for retroperitoneal sarcomas, with diffuse involvement of the adjacent organs in the
abdominal cavity necessitating en bloc resection of the tumour [8]. En bloc resection is
therefore preferred and imperative in cases where large proportions of the tumours encase the
abdominal cavity, infiltrating multiple organs. Previous attempts at neoadjuvant chemotherapy
complementing resection have proved to be futile [6]. Post-operatively, histological analysis of
the tumour is conducted, which is instrumental in confirming the diagnosis of a particular
subtype of liposarcoma [9].
Despite the requirement of negative surgical margins involving resection of the
pseudocapsule, en bloc resection presents a surgical quandary owing to the close proximity of
the tumour to vital organs, such as the great vessels [6]. As a result, en bloc resection of RLS
presents an exacting surgical challenge. Surgeons must prioritize resection based on various
categories, such as considering organ involvement and involvement of the surrounding fat
independently [10]. Muscle and ligament involvement also guides surgeons in assessing the
degree of aggressiveness they must demonstrate while resecting [7]. Striking a balance between
eradicating malignancy and observing patient safety is at the crux of surgical therapy for these
tumours and determines survival outcomes for patients [11]. Therefore, an MDT analysis of
each case with discussion of benefits and drawbacks of the different management options is
pivotal in portending favourable post-operative outcomes [12]. Additionally, intra-operative
bleeding presents a concomitant risk that comes entrenched in surgical resection and must
therefore be minimized [11]. Organ failure and death post-operatively are major complications
of the surgery. Furthermore, atrial fibrillation is another potentially grave complication that
can ensue due to the haemodynamic shifts in blood volumes and atrial stretch during surgery
[11]. Follow-up of patients for the recurrence of symptoms is therefore crucial and in cases
deemed palliative, surgery targeting symptomatic relief is warranted [13]. 
Conclusions
Due to their location in the hollow abdomen, RLS often present late in the disease course,
remaining clinically silent and thus evading prompt detection. Clinical manifestations elicited
by retroperitoneal sarcomas are often vague, and most often present only with exorbitant
tumour growth and subsequent encasement of the adjacent structures. En bloc resection is thus
warranted, presenting an exacting surgical challenge. 
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